Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.26

-1.02

-0.78

-0.53

Details

Expected EPS

-0.7491999238999999

Actual EPS

-0.534462

Surprise EPS

0.21

Surprise Percent

+28.66%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.534462 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.